Nanoparticles containing gliadin could allow celiac disease patients to eat a normal diet

Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, but are often symptom-free.

Source link

Related posts

FDA approves Hadlima, fourth Humira biosimilar


Applicability of common inflammatory markers in diagnosing infections in early period after liver transplantation in intensive care setting


Metabolite crosstalk could modulate chemotherapy response in pancreatic cancer


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World